Company Filing History:
3 out of 8 
2 out of 55 
2 out of 846 
Years Active: 1985-1989
Title: Mitsuaki Yoshida: Innovator in Cancer Research
Introduction
Mitsuaki Yoshida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of antibodies related to human leukemia. With a total of five patents to his name, Yoshida's work has had a profound impact on the diagnosis and treatment of leukemia.
Latest Patents
Yoshida's latest patents include innovative methods for producing antibodies to human leukemia virus-related peptides. One notable patent describes a process for obtaining an antibody produced in a mammal by administering an antigen prepared from a human leukemia virus-related peptide. This peptide is derived from the adult T cell leukemia virus antigen. Additionally, he has developed recombinant plasmids that insert a DNA fragment coding for a fused protein of the adult T cell leukemia virus antigen peptide and an enzyme into vector DNA. These microorganisms are then transformed and cultured to express the fused protein, which is useful for the detection and diagnosis of adult T cell leukemia.
Career Highlights
Throughout his career, Mitsuaki Yoshida has worked with esteemed organizations such as the Juridical Foundation and the Japanese Foundation for Cancer Research. His dedication to advancing cancer research has positioned him as a key figure in the scientific community.
Collaborations
Yoshida has collaborated with notable colleagues, including Haruo Sugano and Fumio Shimizu. Their combined expertise has contributed to the success of various research projects and innovations in the field.
Conclusion
Mitsuaki Yoshida's contributions to cancer research through his innovative patents and collaborations highlight his importance in the scientific community. His work continues to pave the way for advancements in the diagnosis and treatment of leukemia.